🔎 Trials Near Me

Home › Type 2 Diabetes › Texas › McKinney

Type 2 Diabetes clinical trials in McKinney, TX

6 studies for Type 2 Diabetes are looking for participants at sites in and around McKinney (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

RecruitingHealthy volunteers welcome
  • North Dallas Research Associates - Kerlo Network, McKinney
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

RecruitingPhase 2
  • Revival Research Institute, LLC, McKinney
  • Texas Institute of Cardiology, PA, McKinney
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

RecruitingPhase 2
  • Sunbeam Clinical Research, McKinney
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

RecruitingPhase 3
  • Research Site, McKinney
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662109

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Recruiting
  • Tekton Research, McKinney
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07521475

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

RecruitingPhase 2
  • Tekton Research, McKinney
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07546929

About Type 2 Diabetes

Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.

More about Type 2 Diabetes on MedlinePlus

Type 2 Diabetes trials in other cities

Other studies in McKinney

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.